Standout Papers
Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Thrombosis in vasculitis: from pathogenesis to treatment
2015
Optical coherence tomography angiography
2017 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Th1 polarization of the immune response in Beh�et's disease: A putative pathogenetic role of interleukin-12
1999
Randomized, Double-Masked Study of Cyclosporine Compared to Prednisolone in the Treatment of Endogenous Uveitis
1991
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Surfactant protein D regulates chemotaxis and degranulation of human eosinophils
2006
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Low-dose Cyclosporine Therapy in the Treatment of Birdshot Retinochoroidopathy
1994
FUNCTIONAL AND STRUCTURAL CHARACTERISTICS OF EXPERIMENTAL FK 506 NEPHROTOXICITY
1995
Prevalence of Behçet's disease in Istanbul, Turkey
2003
Immunotherapy of autoimmunity and cancer: the penalty for success
2008
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Natural products: An evolving role in future drug discovery
2011 Standout
Interplay between innate and adaptive immunity in the development of non-infectious uveitis
2011
Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot study
1998
Pyoderma gangrenosum: Classification and management
1996 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept
2005
Non-IBD and noninfectious colitis
2008
Infliximab Therapy for the Treatment of Refractory Ocular Inflammatory Disease
2007
The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization
2016 StandoutNobel
Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation
2004 StandoutNobel
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Mucosal immunity and vaccines
2005 Standout
Sustained delivery of a HIF-1 antagonist for ocular neovascularization
2013 StandoutNobel
Mouse Models of Experimental Autoimmune Uveitis
2008
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report
2001
Vascular disorders of the liver # †
2008 Standout
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
2000 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
2004
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
2003
Cyclosporin
1993
Cd45rc- γδ+ T–Cell Infiltration Is Associated With Immunologic Unresponsiveness Induced by Prior Donor–Specific Blood Transfusion in Rat Hepatic Allografts
2001
Crohn's disease
2016 Standout
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Ankylosing spondylitis
2007 Standout
FK506 Treatment of Noninfectious Uveitis
1994
Immunology and functional genomics of Beh�et's disease
2003
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
A Controlled Trial of Azathioprine in Behçet's Syndrome
1990
Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells
2006
TAXI/UAS: A Molecular Switch to Control Expression of Genes In Vivo
1996 StandoutNobel
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study
2007 Standout
Adalimumab in the therapy of uveitis in childhood
2006
A clinical review of 105 patients with PFAPA (a periodic fever syndrome)
2009
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Neutrophilic vascular reactions
1988
Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine
1999
Expansion of γδ T-cells in Behçet's disease: Role of disease activity and microbial flora in oral ulcers
2003
Anti–tumor necrosis factor-α therapy in uveitis
2015
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Behçet's disease: a new target for anti-tumour necrosis factor treatment
2002
Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A
1994
Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells
1995
Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages
2008
Next-generation calcineurin inhibitors for ophthalmic indications
2007
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Vγ9Vδ2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens
2002
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Management of Crohn's Disease in Adults
2009 Standout
Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis
1998
Treatment with infliximab for a child with Behçet's disease
2003
Pro-inflammatory cellular immune response in Behçet’s disease
2007
GENETIC CONTROL OF SUSCEPTIBILITY IN CLINICAL AND EXPERIMENTAL UVEITIS
2002
Budd–Chiari syndrome: Long‐term effect on outcome with transjugular intrahepatic portosystemic shunt
2005
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
Efficacy of TNF blockade in cyclophosphamide resistant neuro-Behcet disease
2005
Hipertensión: factor de riesgo en obesidad canina [Caso clínico presentado en el 29 Congreso Nacional de AVEPA, 22-24 Octubre 2004, Madrid]
2005
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Maturation of the hemostatic system during childhood
1992 Standout
Oral tolerization with peptide 336–351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease
2004
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
2010 StandoutNobel
Low-Dose Cyclosporine for the Treatment of Crohn's Disease
1994
The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare
1997
Ischemic Retinal Vasculitis and Its Management
2014
Preliminary report: cyclosporin in treatment of severe active ulcerative colitis
1990
The SDF‐1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization
2007
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
2005 Standout
IL-4 and IL-13 Form a Negative Feedback Circuit with Surfactant Protein-D in the Allergic Airway Response
2006
Txk, a Nonreceptor Tyrosine Kinase of the Tec Family, Is Expressed in T Helper Type 1 Cells and Regulates Interferon γ Production in Human T Lymphocytes
1999
The Hypercoagulable States
1985
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies
2016 Standout
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
2007
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Chronic granulomatous disease presenting as an oculomucocutaneous syndrome mimicking Behçet's syndrome
1986
Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial.
1992
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
TNF‐mediated inflammatory disease
2007 Standout
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Behcet’s Disease: Systemic and Ocular Manifestations
2013
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel
Works of Goro Inaba being referenced
Association of HLA‐B51 and lack of association of class II alleles with Behcet's disease
1992
Behçet's Disease
1999 Standout
DOUBLE-MASKED TRIAL OF CYCLOSPORIN VERSUS COLCHICINE AND LONG-TERM OPEN STUDY OF CYCLOSPORIN IN BEHÇET'S DISEASE
1989
A Clinical Trial of FK506 in Refractory Uveitis
1993
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis.
2004
Role of γδ T lymphocytes in the development of Behc¸et's disease
1997
Behçet disease (Behçet syndrome)
1979
Cellular autoimmunity to retinal specific antigens in patients with Behcet's disease.
1993
Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
1989